FYZOCLAD Trademark

Trademark Overview

On Thursday, May 16, 2019, a trademark application was filed for FYZOCLAD with the United States Patent and Trademark Office. The USPTO has given the FYZOCLAD trademark a serial number of 88433779. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 31, 2022. This trademark is owned by Pfizer Inc.. The FYZOCLAD trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
fyzoclad

General Information

Serial Number88433779
Word MarkFYZOCLAD
Filing DateThursday, May 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, October 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 4 GRANTED
Thursday, February 24, 2022SOU EXTENSION 4 FILED
Thursday, February 24, 2022TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 3 GRANTED
Monday, September 13, 2021SOU EXTENSION 3 FILED
Monday, September 13, 2021TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 2 GRANTED
Friday, February 26, 2021SOU EXTENSION 2 FILED
Friday, February 26, 2021TEAS EXTENSION RECEIVED
Wednesday, August 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 24, 2020SOU EXTENSION 1 GRANTED
Monday, August 24, 2020SOU EXTENSION 1 FILED
Monday, August 24, 2020TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 13, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 5, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 22, 2019ASSIGNED TO EXAMINER
Monday, June 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 20, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

fyzoclad arthritis colitis ulcerative psoriatic ankylosing idiopathic juvenile spondylitis disease psoriasis